The twiist automated insulin delivery system. [Image courtesy of Sequel] Sequel Med Tech announced today that its partner, ...
Every year, the diabetes community comes together for the International Conference on Advanced Technologies & Treatments for ...
Insulet (Nasdaq:PODD) today announced positive results from a clinical trial pitting its Omnipod 5 against non-automated ...
Know Labs (NYSE:KNW) announced interim results highlighting the accuracy of its non-invasive glucose monitoring sensor.
Ascensia Diabetes Care and Senseonics today announced an extension to their Eversense Payment Assistance and Simple Savings ...
Abbott today announced data from two real-world studies highlighting the success of its CGM when used with GLP-1 drugs.
Roche today gave a presentation debuting its first continuous glucose monitor (CGM) offering that utilizes predictive AI. The ...
This marks the first FDA clearance for a continuous glucose monitoring (CGM) technology for over-the-counter use. In January, ...
Boston Scientific (NYSE:BSX) reported positive investigational device exemption (IDE) trial data for its Agent drug-coated ...
Innovation Zed announced this week that it entered into a strategic partnership with Enhance-D to optimize diabetes therapy.
Medtronic (NYSE:MDT) shared new clinical and real-world evidence backing the use of its MiniMed 780G system around the world.